Department of Pharmaceutical Biochemistry, College of Pharmacy, Kyung Hee University, Seoul, South Korea.
Department of Pharmaceutical Biochemistry, College of Pharmacy, Kyung Hee University, Seoul, South Korea; Department of Life and Nanopharmaceutical Sciences, College of Pharmacy, Kyung Hee University, Seoul, South Korea.
Phytomedicine. 2020 Mar;68:153167. doi: 10.1016/j.phymed.2019.153167. Epub 2020 Jan 23.
The roots of Partrinia scabra have been used as a medicinal herb in Asia. We previously reported that the inhibitory effect of patriscabrin F on lipopolysaccharide (LPS)-induced nitric oxide (NO) production was the most potent than that of other isolated iridoids from the roots of P. scabra.
We investigated the anti-inflammatory activity of patriscabrin F as an active compound of P. scabra and related signaling cascade in LPS-activated macrophages.
The anti-inflammatory activities of patriscabrin F were determined according to its inhibitory effects on NO, prostaglandin E (PGE), and pro-inflammatory cytokines. The molecular mechanisms were revealed by analyzing nuclear factor-κB (NF-κB), activator protein-1 (AP-1), interferon regulatory factor 3 (IRF3), and Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway.
Patriscabrin F inhibited the LPS-induced production of NO, PGE tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6 in both bone-marrow derived macrophages (BMDMs) and RAW 264.7 macrophages. Patriscabrin F downregulated LPS-induced inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), TNF-α, IL-1β, and IL-6 at the transcriptional level. Patriscabrin F suppressed LPS-induced NF-κB activation by decreasing p65 nuclear translocation, inhibitory κBα (IκBα) phosphorylation, and IκB kinase (IKK)α/β phosphorylation. Patriscabrin F attenuated LPS-induced AP-1 activity by inhibiting c-Fos phosphorylation. Patriscabrin F suppressed the LPS-induced phosphorylation of IRF3, JAK1/JAK2, and STAT1/STAT3.
Taken together, our findings suggest patriscabrin F may exhibit anti-inflammatory properties via the inhibition of NF-κB, AP-1, IRF3, and JAK-STAT activation in LPS-induced macrophages.
白头翁的根在亚洲被用作草药。我们之前报道过,patriscabrin F 抑制脂多糖(LPS)诱导的一氧化氮(NO)产生的作用比白头翁根中其他分离出的环烯醚萜苷更有效。
我们研究了 patriscabrin F 作为白头翁的活性化合物的抗炎活性及其在 LPS 激活的巨噬细胞中的相关信号级联。
根据对 NO、前列腺素 E(PGE)和促炎细胞因子的抑制作用,测定 patriscabrin F 的抗炎活性。通过分析核因子-κB(NF-κB)、激活蛋白-1(AP-1)、干扰素调节因子 3(IRF3)和 Janus 激酶(JAK)/信号转导和转录激活因子 3(STAT)途径,揭示其分子机制。
patriscabrin F 抑制骨髓来源的巨噬细胞(BMDMs)和 RAW 264.7 巨噬细胞中 LPS 诱导的 NO、PGE、肿瘤坏死因子-α(TNF-α)、白细胞介素(IL)-1β 和 IL-6 的产生。patriscabrin F 下调 LPS 诱导的诱导型一氧化氮合酶(iNOS)和环加氧酶-2(COX-2)、TNF-α、IL-1β 和 IL-6 的转录水平。patriscabrin F 通过减少 p65 核易位、抑制κBα(IκBα)磷酸化和 IκB 激酶(IKK)α/β 磷酸化来抑制 LPS 诱导的 NF-κB 激活。patriscabrin F 通过抑制 c-Fos 磷酸化来抑制 LPS 诱导的 AP-1 活性。patriscabrin F 抑制 LPS 诱导的 IRF3、JAK1/JAK2 和 STAT1/STAT3 磷酸化。
综上所述,我们的研究结果表明,patriscabrin F 可能通过抑制 LPS 诱导的巨噬细胞中 NF-κB、AP-1、IRF3 和 JAK-STAT 的激活来发挥抗炎作用。